Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis

Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic Fibrosis

(2013) Stefanie Hennig et al.   CLINICAL PHARMACOKINETICS

Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity

(2013) Manjunath P. Pai et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis

(2013) S. Alghanem et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safe and Effective Variability—A Criterion for Dose Individualization

(2012) Nicholas H.G. Holford et al.   THERAPEUTIC DRUG MONITORING

Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin

(2011) Stefanie Hennig et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Measurement and Estimation of GFR in Children and Adolescents

(2009) G. J. Schwartz et al.   Clinical Journal of the American Society of Nephrology

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis – a population pharmacokinetic study

(2007) Stefanie Hennig et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY